Hope for ALS patients


Published On: May 28th, 2010

Val Kennedy talks with Cytokinetics’ CEO Robert Blum about a new drug the company hopes will be able to boost muscle function in patients with ALS, or Lou Gehrig’s disease.

See the rest here: 
Hope for ALS patients/a>



Loading...


Comments are closed.